Role of interleukin-2 activated MHC-nonrestricted lymphocytes in antileukemia activity and therapy. [electronic resource]
- Leukemia & lymphoma May 1992
- 15-28 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.; Review
1042-8194
10.3109/10428199209053598 doi
Bone Marrow--immunology Cytotoxicity, Immunologic--drug effects Humans Interleukin-2--pharmacology Killer Cells, Lymphokine-Activated--drug effects Leukemia--immunology Major Histocompatibility Complex T-Lymphocytes--drug effects